CVE-2026-120295nerves-hub nerves_hub_web incorrect authorization
CVE-2026-120295 is a incorrect authorization in nerves-hub nerves_hub_web, rated high (7.1 on CVSS 4.0).
Why this priority: High severity, with no exploitation signal yet.
Published · Updated · NVD status: Received
What it is
A permission check exists but gets the answer wrong for some callers.
How it is reached
An attacker can exploit it over the network, with an ordinary user account, and nobody has to click anything.
What an attacker gains
A successful attack can read the data it protects. In practice, this kind of flaw lets an attacker reach data or actions their role should not allow.
Is it being exploited?
There is no public report of exploitation yet.
What to do
- Upgrade nerves-hub nerves_hub_web to 2.5.3 or later.
- Until it is patched, review who holds accounts that can reach it.
Description from NVD
Incorrect Authorization vulnerability in the devices page bulk move in nerves-hub nerves_hub_web allows an authenticated user with the manage role in one organization and only the view role in another to move devices into the second organization's product via the "Move device(s) to product" action. The target-product event in NervesHubWeb.Live.Devices.Index looks the product up with NervesHub.Products.get_by_id/2, which checks that the user is a member of the product's organization at any role, and move-devices-product then changes each selected device's organization and product. The device API's move requires manage in the target organization, and an earlier fix added the check on the organization the devices leave but not on the one they enter.
A moved device keeps its key and certificate, joins the target organization's matching deployment groups, and is sent their firmware with a download URL, which the view role cannot otherwise obtain. The user cannot change or control devices that already belong to the other organization.
This issue affects nerves_hub: from 1.0.0 before 2.5.3.
What this means for your architecture.
A CVE names a product. Whether it matters depends on where that product sits in your systems: what reaches it, which trust boundary it guards and what it can reach once compromised. Veriom maps your components, their relationships and your trust boundaries from your code, cloud and delivery evidence, so you can see where a component like this sits. The radar itself does not look at your systems.
Components it touches
- Permission checks in APIs and admin surfaces. The flaw sits between one role or tenant and another.
- Multi-tenant services. The flaw sits between one role or tenant and another.
Trust boundaries in play
- Authenticated network access. An account is needed, so exposure follows who can sign in: customers, partners or staff.
- Between one role or tenant and another. An attacker who crosses it can reach data or actions their role should not allow.
Questions to answer about your own systems
- Where does nerves-hub nerves_hub_web run in your systems, and at which version?
- Which of those instances can be reached from the internet or partner networks?
- What can it reach once compromised: which data stores, secrets and services?
Read more
Patches and commits
Sources
- CVE records and CVSS scores from the NVD CVE API. This product uses the NVD API but is not endorsed or certified by the NVD.
- Exploitation status from CISA’s Known Exploited Vulnerabilities catalog.
- Exploit likelihood from FIRST’s Exploit Prediction Scoring System (EPSS), refreshed daily.
- Explanations are written by Veriom from fixed templates over each record’s data, not by a person reviewing each CVE. Descriptions are quoted from the records as published.